KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 131 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $569,381 | +30.9% | 40,439 | 0.0% | 0.08% | +32.2% |
| Q1 2023 | $435,124 | +2.6% | 40,439 | +42.9% | 0.06% | -14.5% |
| Q4 2022 | $424,054 | -4.9% | 28,308 | -18.5% | 0.07% | +3.0% |
| Q3 2022 | $446,000 | -10.4% | 34,747 | -32.4% | 0.07% | +52.3% |
| Q2 2022 | $498,000 | -24.4% | 51,379 | -22.5% | 0.04% | -22.8% |
| Q1 2022 | $659,000 | – | 66,276 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |